Web2 mrt. 2016 · CSL Behring engineered IDELVION® to extend the half-life of recombinant factor IX through fusion with recombinant albumin. CSL Behring selected recombinant albumin as its fusion partner for its coagulation factor proteins due to its long physiological half-life. IDELVION® is approved in Canada. Websuch cancellation to CSL Behring c/o Patient Services P.O. Box 61501 King of Prussia, PA 19406 or by calling the CSL Behring Customer Affairs toll free number 1-888-508-6978 and that this cancellation will end my participation in CSL Behring Services and will not apply to any information already used or disclosed through this authorization
About Idelvion for Payers
WebIDELVION ®, Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rFIX-FP), is indicated in children and adults with hemophilia B (congenital Factor IX deficiency) for: On-demand treatment and control of bleeding episodes Perioperative management of bleeding Routine prophylaxis to reduce the frequency of bleeding episodes WebOur Focus on Serious & Rare Diseases. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency. Read More. labrum tear anchors
Contact Us IDELVION coagulation factor IX (recombinant), …
Web©2024 CSL Behring LLC 1020 First Avenue, PO Box 61501, King of Prussia, PA 19406-0901 USA www.CSLBehring.com www.IDELVION.com IDL-0450-OCT22 Created Date WebShe joined CSL Behring in 2011 and has held increasingly broader roles including serving as the therapeutic head of coagulation, acquired bleeding, oncology, immunology, critical … WebIDELVION CSL Behring Products Welcome to the CSL Behring Healthcare Professional Hub. Log In or Register Product information, education and support materials to assist … promotional codes for sports direct